Secretory phospholipase-A2 and fatty acid composition in oral reactive lesions: a cross-sectional study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2867
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Secretory phospholipase-A2 and fatty acid composition in oral reactive lesions: a cross-sectional study ; volume:17 ; number:1 ; day:27 ; month:4 ; year:2017 ; pages:1-7 ; date:12.2017
Cancer cell international ; 17, Heft 1 (27.4.2017), 1-7, 12.2017
- Creator
-
Mesgarzadeh, Ali Hossein
- Contributor
-
Akbarzadeh, Abolfazl
Rasipour, Ali
Rasipour, Tannaz
Mehdizadeh, Amir
Shaaker, Maghsod
SpringerLink (Online service)
- DOI
-
10.1186/s12935-017-0414-x
- URN
-
urn:nbn:de:1111-201705101779
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mesgarzadeh, Ali Hossein
- Akbarzadeh, Abolfazl
- Rasipour, Ali
- Rasipour, Tannaz
- Mehdizadeh, Amir
- Shaaker, Maghsod
- SpringerLink (Online service)
Other Objects (12)
A secretory phospholipase A2-mediated neuroprotection and anti-apoptosis
Characterization of plasma secretory phospholipase A2 activity in the prairie rattlesnake (Crotalus viridis)
Effect of intensive insulin treatment on plasma levels of lipoprotein-associated phospholipase A2 and secretory phospholipase A2 in patients with newly diagnosed type 2 diabetes
Surfactant Protein B Suppresses Lung Cancer Progression by Inhibiting Secretory Phospholipase A2 Activity and Arachidonic Acid Production
Secretory phospholipase A2 pathway in various types of lung injury in neonates and infants: a multicentre translational study
Reduction of lipoxidative load by secretory phospholipase A2 inhibition protects against neurovascular injury following experimental stroke in rat
Plasma secretory phospholipase A2-IIa as a potential biomarker for lung cancer in patients with solitary pulmonary nodules
Endothelial protein C receptor-associated invasiveness of rheumatoid synovial fibroblasts is likely driven by group V secretory phospholipase A2
Bilateral co-secretory lesions presenting with coexisting Cushing syndrome and primary aldosteronism: a case report
Comparative efficacy of a secretory phospholipase A2 inhibitor with conventional anti-inflammatory agents in a rat model of antigen-induced arthritis
Polydatin up-regulates clara cell secretory protein to suppress phospholipase A2 of lung induced by LPS in vivo and in vitro
![Synthese von Oxocarbonsäuren als potentielle Phospholipase-A2-Hemmer [Phospholipase-A-Hemmer]](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Synthese von Oxocarbonsäuren als potentielle Phospholipase-A2-Hemmer [Phospholipase-A-Hemmer]
A secretory phospholipase A2-mediated neuroprotection and anti-apoptosis
Characterization of plasma secretory phospholipase A2 activity in the prairie rattlesnake (Crotalus viridis)
Effect of intensive insulin treatment on plasma levels of lipoprotein-associated phospholipase A2 and secretory phospholipase A2 in patients with newly diagnosed type 2 diabetes
Surfactant Protein B Suppresses Lung Cancer Progression by Inhibiting Secretory Phospholipase A2 Activity and Arachidonic Acid Production
Secretory phospholipase A2 pathway in various types of lung injury in neonates and infants: a multicentre translational study
Reduction of lipoxidative load by secretory phospholipase A2 inhibition protects against neurovascular injury following experimental stroke in rat
Plasma secretory phospholipase A2-IIa as a potential biomarker for lung cancer in patients with solitary pulmonary nodules
Endothelial protein C receptor-associated invasiveness of rheumatoid synovial fibroblasts is likely driven by group V secretory phospholipase A2
Bilateral co-secretory lesions presenting with coexisting Cushing syndrome and primary aldosteronism: a case report
Comparative efficacy of a secretory phospholipase A2 inhibitor with conventional anti-inflammatory agents in a rat model of antigen-induced arthritis
Polydatin up-regulates clara cell secretory protein to suppress phospholipase A2 of lung induced by LPS in vivo and in vitro
Synthese von Oxocarbonsäuren als potentielle Phospholipase-A2-Hemmer [Phospholipase-A-Hemmer]
A secretory phospholipase A2-mediated neuroprotection and anti-apoptosis
Characterization of plasma secretory phospholipase A2 activity in the prairie rattlesnake (Crotalus viridis)
Effect of intensive insulin treatment on plasma levels of lipoprotein-associated phospholipase A2 and secretory phospholipase A2 in patients with newly diagnosed type 2 diabetes
Surfactant Protein B Suppresses Lung Cancer Progression by Inhibiting Secretory Phospholipase A2 Activity and Arachidonic Acid Production
Secretory phospholipase A2 pathway in various types of lung injury in neonates and infants: a multicentre translational study
Reduction of lipoxidative load by secretory phospholipase A2 inhibition protects against neurovascular injury following experimental stroke in rat
Plasma secretory phospholipase A2-IIa as a potential biomarker for lung cancer in patients with solitary pulmonary nodules
Endothelial protein C receptor-associated invasiveness of rheumatoid synovial fibroblasts is likely driven by group V secretory phospholipase A2
Bilateral co-secretory lesions presenting with coexisting Cushing syndrome and primary aldosteronism: a case report
Comparative efficacy of a secretory phospholipase A2 inhibitor with conventional anti-inflammatory agents in a rat model of antigen-induced arthritis
Polydatin up-regulates clara cell secretory protein to suppress phospholipase A2 of lung induced by LPS in vivo and in vitro